Hepatitis can be acute (sudden and severe) or chronic (persistent or recurrent). Some chronic infections can cause liver scarring, cirrhosis, liver cancer, and liver failure. Symptoms of hepatitis ...

ACUTE viral hepatitis of both the epidemic and * serum varieties continues to be a common medical illness and is regarded correctly as a typical benign, self-limited disease. Despite ...

While acute hepatitis C is often asymptomatic, over half of hepatitis C cases lead to chronic infection. This can be life threatening. Because of this, chronic hepatitis C requires treatment.

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

The historical record shows that the battle to prevent and find cures for infectious disease will lead to a lower incidence of chronic, disabling diseases. At the same time, efforts to find ...

In Europe, the introduction of HBV vaccination has markedly reduced the incidence of acute HBV ... [1] Since 1992, the inclusion of hepatitis B vaccination has been recommended by the WHO in ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

causing both acute and chronic diseases in hundreds of millions of people, adding that they were all together the most common causes of liver cirrhosis, liver cancer and viral hepatitis-related ...

The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...

The US FDA has granted breakthrough therapy designation to Bluejay Therapeutics’ brelovitug, to treat chronic hepatitis delta ...